Phase 1 pharmacokinetic study of the oral pan-AKT inhibitor MK-2206 in Japanese patients with advanced solid tumors
Crossref DOI link: https://doi.org/10.1007/s00280-015-2810-z
Published Online: 2015-06-24
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Doi, Toshihiko
Tamura, Kenji
Tanabe, Yuko
Yonemori, Kan
Yoshino, Takayuki
Fuse, Nozomu
Kodaira, Makoto
Bando, Hideaki
Noguchi, Kazuo
Shimamoto, Takashi
Ohtsu, Atsushi
License valid from 2015-06-24